Eton Pharmaceuticals Q1 2026 Earnings EPS Miss Triggers Stock Decline ATLCZ Q1 2026 Earnings Strong EPS Beat Highlights Solid Operational Performance StoneX Group Inc SNEX Q1 2026 Earnings EPS Surges Past Estimates with 365 Beat FGBI Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Decline NCSM Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions SWKH Q3 2025 Earnings Strong EPS Beat Driven by Investment Gains and Portfolio Performance CWCO Q1 2026 Earnings EPS Misses Estimates by 1327 as Stock Edges Higher QNRX Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment KMT Q1 2026 Earnings Earnings Beat Estimates by 1345 Shares Edge Higher PAM Q1 2026 Earnings Stellar Earnings Beat Driven by Exceptional Operational Performance Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues INMB Q4 2025 Earnings EPS Surpasses Estimates as Loss Narrows PMV Pharmaceuticals PMVP Q1 2026 Earnings Narrower Loss Provides a Glimmer of Operational Efficiency